Feasibility and Application of Membrane Aerated Biofilm Reactors for Industrial Wastewater Treatment

Abstract

Membrane aerated biofilm reactors (MABRs) have emerged as a promising technology for wastewater treatment, offering significant advantages over conventional activated sludge (CAS) systems. Over the past decades, membrane processes have revolutionized municipal water treatment with membrane bioreactors (MBRs) becoming a widely accepted process for municipal and then industrial wastewater (IW) treatment. By the same token, MABR technologies were initially applied to municipal wastewater; however, their application in industrial settings is still emerging. Despite the promise of MABRs due to the biofilm's tolerance to IW toxins, there is a lack of information on their industrial applications. Therefore, this paper critically reviews the feasibility and application of MABRs for IW treatment, including pharmaceutical, chemical, refinery, petrochemical, oilfield, landfill leachate and other complex industrial waters. Three existing technology vendors with full-scale experience were compared; however, additional providers with innovative designs may provide step-changes in performance. Key outcomes highlight the effectiveness of MABRs in reducing carbon, nitrogen, and xenobiotics from high-strength IWs at bench and pilot scales. Critical factors influencing MABR performance, such as biofilm thickness (BT) were correlated to organics and nitrogen removal efficiency in industrial applications. Review of advances in MABR modeling techniques showed that current models lack the needed resolution for large and dynamic industrial systems. Additionally, the review compares municipal and industrial applications of MABRs, emphasizing the unique challenges and innovations required for their adoption in IW treatment. Overall, the MABR process was found to be feasible for industrial applications with pilot and/or demonstration-scale testing being necessary to further optimize process performance.